| Dr Dustin P Andresen, MD | |
|
1000 E Main St, Danville, IN 46122-1948 | |
| (317) 718-4740 | |
| Not Available |
| Full Name | Dr Dustin P Andresen |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 13 Years |
| Location | 1000 E Main St, Danville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528356805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 60041-20 (Wisconsin) | Secondary |
| 208M00000X | Hospitalist | 01088329A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
The Los Angeles Times explores some key questions: Will insurers continue to raise premiums; when will the Medicare "doughnut hole" close; and, "how do I sign up for my new insurance?" In answer to the last one, the Times writes, "Although there are some provisions that take effect this year, such as bans on lifetime limits and the denial of coverage to children with pre-existing conditions, the part of the bill that provides new insurance options does not take effect until 2014" (Geiger, 3/28).
Dean Sittig, Ph.D., professor at The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics, received a Book of the Year Award from The Healthcare Information and Management Systems Society (HIMSS).
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
The outcome of tuberculosis infection in mice depends in part on how quickly bacteria-fighting T cells can get to the lungs. According to a new study that will appear online on June 14th in the Journal of Experimental Medicine, another group of T cells delays their arrival.
Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments.
› Verified 4 days ago
| Entity Name | Hendricks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
The Los Angeles Times explores some key questions: Will insurers continue to raise premiums; when will the Medicare "doughnut hole" close; and, "how do I sign up for my new insurance?" In answer to the last one, the Times writes, "Although there are some provisions that take effect this year, such as bans on lifetime limits and the denial of coverage to children with pre-existing conditions, the part of the bill that provides new insurance options does not take effect until 2014" (Geiger, 3/28).
Dean Sittig, Ph.D., professor at The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics, received a Book of the Year Award from The Healthcare Information and Management Systems Society (HIMSS).
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
The outcome of tuberculosis infection in mice depends in part on how quickly bacteria-fighting T cells can get to the lungs. According to a new study that will appear online on June 14th in the Journal of Experimental Medicine, another group of T cells delays their arrival.
Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dustin P Andresen, MD 1000 E Main St, Danville, IN 46122-1948 Ph: (317) 718-4740 | Dr Dustin P Andresen, MD 1000 E Main St, Danville, IN 46122-1948 Ph: (317) 718-4740 |
News Archive
The Los Angeles Times explores some key questions: Will insurers continue to raise premiums; when will the Medicare "doughnut hole" close; and, "how do I sign up for my new insurance?" In answer to the last one, the Times writes, "Although there are some provisions that take effect this year, such as bans on lifetime limits and the denial of coverage to children with pre-existing conditions, the part of the bill that provides new insurance options does not take effect until 2014" (Geiger, 3/28).
Dean Sittig, Ph.D., professor at The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics, received a Book of the Year Award from The Healthcare Information and Management Systems Society (HIMSS).
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
The outcome of tuberculosis infection in mice depends in part on how quickly bacteria-fighting T cells can get to the lungs. According to a new study that will appear online on June 14th in the Journal of Experimental Medicine, another group of T cells delays their arrival.
Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments.
› Verified 4 days ago
Dr. Kevin Michael Hartzell, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-837-5571 Fax: 317-837-5580 | |
Gordon Reed, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-745-3532 Fax: 317-745-8477 | |
Dr. Allie Beckman Sadowitz, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-745-4451 Fax: 317-718-6740 | |
Dr. Samir Ravindra Ginde, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main Street, Danville, IN 46122 Phone: 317-718-4741 Fax: 317-718-6740 |